Kinga Woźniak

927 total citations
37 papers, 782 citations indexed

About

Kinga Woźniak is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Kinga Woźniak has authored 37 papers receiving a total of 782 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Cellular and Molecular Neuroscience, 14 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in Kinga Woźniak's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (5 papers). Kinga Woźniak is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Neuroscience and Neuropharmacology Research (8 papers) and Receptor Mechanisms and Signaling (5 papers). Kinga Woźniak collaborates with scholars based in United States, Poland and Czechia. Kinga Woźniak's co-authors include Charanjit S. Aulakh, Dennis L. Murphy, James Hill, Barbara S. Slusher, Pascale Mazzola‐Pomietto, M. Linnoila, Anders A. F. Sima, Yūichi Murakawa, Leena Hilakivi‐Clarke and Michael J. Durcan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Neurochemistry.

In The Last Decade

Kinga Woźniak

32 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kinga Woźniak United States 17 372 233 182 86 85 37 782
Michael A. Ackley United States 13 401 1.1× 287 1.2× 152 0.8× 99 1.2× 97 1.1× 22 859
Alfredo Oliveros United States 19 353 0.9× 364 1.6× 116 0.6× 72 0.8× 74 0.9× 51 932
Katalin Horváth Hungary 17 271 0.7× 231 1.0× 126 0.7× 132 1.5× 93 1.1× 44 862
Isabelle Leroux‐Nicollet France 20 600 1.6× 344 1.5× 109 0.6× 147 1.7× 73 0.9× 40 1.0k
Eileen Curran United States 12 520 1.4× 448 1.9× 337 1.9× 157 1.8× 119 1.4× 17 1.1k
Tiejun Xu China 12 522 1.4× 410 1.8× 110 0.6× 82 1.0× 71 0.8× 14 992
A. N. Chepkova Germany 14 337 0.9× 259 1.1× 195 1.1× 161 1.9× 63 0.7× 34 891
Carole Puma Canada 14 398 1.1× 243 1.0× 159 0.9× 36 0.4× 112 1.3× 17 694
Giordano Gübert Viola Brazil 16 242 0.7× 131 0.6× 106 0.6× 127 1.5× 39 0.5× 34 753
Sylvia S. White United States 17 499 1.3× 273 1.2× 230 1.3× 81 0.9× 91 1.1× 28 1.0k

Countries citing papers authored by Kinga Woźniak

Since Specialization
Citations

This map shows the geographic impact of Kinga Woźniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kinga Woźniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kinga Woźniak more than expected).

Fields of papers citing papers by Kinga Woźniak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kinga Woźniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kinga Woźniak. The network helps show where Kinga Woźniak may publish in the future.

Co-authorship network of co-authors of Kinga Woźniak

This figure shows the co-authorship network connecting the top 25 collaborators of Kinga Woźniak. A scholar is included among the top collaborators of Kinga Woźniak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kinga Woźniak. Kinga Woźniak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Watała, Cezary, et al.. (2025). Is Insulin Resistance an Independent Predictor of Atherosclerosis?. Journal of Clinical Medicine. 14(3). 969–969. 1 indexed citations
2.
Woźniak, Kinga, et al.. (2024). Anticoagulants - The Past, The Present, The Future - A Systematic Review. SHILAP Revista de lepidopterología. 68. 49539–49539. 2 indexed citations
3.
Woźniak, Kinga, et al.. (2024). Alzheimer's Disease - A Comprehensive Review. SHILAP Revista de lepidopterología. 56. 195–209. 6 indexed citations
4.
Woźniak, Kinga, et al.. (2024). Pectus Excavatum: A review of current treatment possibilities. SHILAP Revista de lepidopterología. 57. 140–153.
5.
Woźniak, Kinga, et al.. (2024). Cutaneous manifestations associated with COVID-19: summary of current knowledge. SHILAP Revista de lepidopterología. 56. 68–82.
6.
Woźniak, Kinga, et al.. (2024). Nutrition Strategies for Optimizing Performance and Health in Young Athletes. SHILAP Revista de lepidopterología. 60. 11–33. 4 indexed citations
7.
Vornov, James J., Kristen R. Hollinger, Paul Jackson, et al.. (2016). Still NAAG’ing After All These Years. Advances in pharmacology. 76. 215–255. 40 indexed citations
8.
Woźniak, Kinga, Sylwester Piaskowski, Ewa Golańska, et al.. (2008). BCR expression is decreased in meningiomas showing loss of heterozygosity of 22q within a new minimal deletion region. Cancer Genetics and Cytogenetics. 183(1). 14–20. 17 indexed citations
9.
Murakawa, Yūichi, et al.. (2006). The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy. Journal of the Neurological Sciences. 247(2). 217–223. 53 indexed citations
10.
Rojas, Camilo, Ajit G. Thomas, Pavel Majer, et al.. (2005). Glutamate Carboxypeptidase II Inhibition as a Novel Therapeutic Target. Kluwer Academic Publishers eBooks. 524. 205–213. 4 indexed citations
11.
Tang, Zhi, et al.. (2005). 2-MPPA, a selective inhibitor of PSMA, delays prostate cancer growth and attenuates taxol-induced neuropathy in mice. Journal of Clinical Oncology. 23(16_suppl). 8054–8054. 3 indexed citations
12.
Lumley, Lucille A., et al.. (2004). Reduced isolation-induced aggressiveness in mice following NAALADase inhibition. Psychopharmacology. 171(4). 375–381. 28 indexed citations
13.
Tentori, Lucio, Carlo Leonetti, Marco Scarsella, et al.. (2004). Oral administration of the PARP-1 inhibitor GPI 15427 increases the anti-tumor activity of temozolomide against melanoma growing at the CNS site. Cineca Institutional Research Information System (Tor Vergata University). 45. 2007. 1 indexed citations
14.
Mazzola‐Pomietto, Pascale, Charanjit S. Aulakh, Kinga Woźniak, & Dennis L. Murphy. (1996). Evidence thatm-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors. Psychopharmacology. 123(4). 333–339. 34 indexed citations
15.
Aulakh, Charanjit S., Joseph Zohar, Kinga Woźniak, James Hill, & Dennis L. Murphy. (1991). Differential effect of lithium treatment on fenfluramine-induced decreases in food intake and locomotor activity in rats. Journal of Psychopharmacology. 5(2). 149–154. 3 indexed citations
16.
Aulakh, Charanjit S., et al.. (1991). Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats. Pharmacology Biochemistry and Behavior. 39(1). 91–95. 7 indexed citations
17.
Woźniak, Kinga, Charanjit S. Aulakh, James Hill, & Dennis L. Murphy. (1989). Hyperthermia induced by m-CPP in the rat and its modification by antidepressant treatments. Psychopharmacology. 97(2). 269–274. 37 indexed citations
18.
Aulakh, Charanjit S., Kinga Woźniak, James Hill, & Dennis L. Murphy. (1988). Long-term imipramine treatment differentially affects fenfluramine-induced suppression of food intake and locomotor activity. Pharmacology Biochemistry and Behavior. 31(1). 97–101. 8 indexed citations
19.
Aulakh, Charanjit S., James Hill, Kinga Woźniak, & Dennis L. Murphy. (1988). Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline. Psychopharmacology. 95(3). 313–7. 18 indexed citations
20.
Aulakh, Charanjit S., Joseph Zohar, Kinga Woźniak, James Hill, & Dennis L. Murphy. (1988). Clorgyline treatment differentially affects m-chlorophenylpiperazine-induced neuroendocrine changes. European Journal of Pharmacology. 150(3). 239–246. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Ackley Breakdown of academic impact, for papers by Alfredo Oliveros Breakdown of academic impact, for papers by Katalin Horváth Breakdown of academic impact, for papers by Isabelle Leroux‐Nicollet Breakdown of academic impact, for papers by Eileen Curran Breakdown of academic impact, for papers by Tiejun Xu Breakdown of academic impact, for papers by A. N. Chepkova Breakdown of academic impact, for papers by Carole Puma Breakdown of academic impact, for papers by Giordano Gübert Viola Breakdown of academic impact, for papers by Sylvia S. White
Rankless by CCL
2026